MEREO BIOPHARMA GROUP PL-ADR (MREO) Stock Balance Sheet
NASDAQ:MREO - Nasdaq - US5894921072 - ADR - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | 2.74M | 6.33M | 93.70M | 31.34M | |||
| Cash Equivalents | 69.80M | 57.42M | 61.82M | 127.57M | 748.00K | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 1.47M | 2.55M | 3.23M | 3.01M | 6.34M | |||
| Other Current Assets | 3.49M | 3.79M | 3.78M | 3.79M | 2.21M | |||
| Total Current Assets | 74.76M | 63.76M | 75.16M | 134.38M | 40.64M | |||
| Non-Current Assets | ||||||||
| PPE Net | 984.00K | 1.65M | 2.21M | 3.42M | 2.15M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | 643.00K | 1.09M | 29.17M | 27.27M | 43.27M | |||
| Total Non-Current Assets | 1.63M | 2.74M | 31.39M | 30.69M | 45.42M | |||
| TOTAL ASSETS | 76.39M | 66.50M | 106.55M | 165.07M | 86.07M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 5.54M | 0.00 | 13.97M | 842.00K | 870.00K | |||
| Accrued Expenses | 4.51M | 5.74M | 5.43M | 5.18M | 5.71M | |||
| Accounts Payable | 2.44M | 2.35M | 3.49M | 3.38M | 4.33M | |||
| Other Current Liabilities | 1.36M | 1.40M | 6.96M | 3.78M | 801.00K | |||
| Total Current Liabilities | 13.85M | 9.49M | 29.85M | 13.18M | 11.71M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 4.39M | 1.48M | 21.83M | 23.65M | |||
| Other Non-Current Liabilities | 1.57M | 2.08M | 376.00K | 11.39M | 71.17M | |||
| Total Non-Current Liabilities | 1.57M | 6.48M | 1.85M | 33.22M | 94.83M | |||
| TOTAL LIABILITIES | 15.42M | 15.96M | 31.71M | 46.39M | 106.54M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -462.88M | -419.63M | -231.15M | -216.49M | -288.34M | |||
| Additional Paid In Capital | 539.64M | 486.11M | 307.63M | 334.79M | 221.21M | |||
| Common Shares | 3.06M | 2.77M | 2.27M | 2.37M | 1.39M | |||
| Treasury Stock | 0.00 | -1.23M | N/A | N/A | N/A | |||
| Other Shareholders' Equity | -18.85M | -17.48M | -3.90M | -2.00M | 45.27M | |||
| Shares Outstanding | 159.14M | 143.85M | 128.20M | 119.99M | 69.53M | |||
| Tangible Book Value per Share | 0.08 | 0.07 | 0.07 | 0.16 | -0.19 | |||
| Total Shareholders' Equity | 60.97M | 50.54M | 74.84M | 118.67M | -20.47M | |||
| TOTAL LIABILITIES AND EQUITY | 76.39M | 66.50M | 106.55M | 165.07M | 86.07M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.09 | 0.02 | 0.18 | -1.16 | |||
| Current Ratio | 5.40 | 6.72 | 2.52 | 10.20 | 3.47 | |||
| Return On Assets (ROA) | -56.62% | -44.31% | -39.54% | 10.60% | -243.76% | |||
| Return On Equity (ROE) | -70.94% | -58.31% | -56.29% | 14.74% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21